Cleared Traditional

K990515 - MATHIS VERTEBRAL AND BONE BIOPSY SYSTEM

K990515 is an FDA 510(k) clearance for MATHIS VERTEBRAL AND BONE BIOPSY SYSTEM, manufactured by International Medical Systems. The device is a Class 2 Gastroenterology & Urology device with product code KNW cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K990515 · International Medical Systems · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1999
Decision
84d
Days
Class 2
Risk

K990515 is an FDA 510(k) clearance for the MATHIS VERTEBRAL AND BONE BIOPSY SYSTEM. Classified as Instrument, Biopsy (product code KNW), Class II - Special Controls.

Submitted by International Medical Systems (Annapolis, US). The FDA issued a Cleared decision on May 13, 1999 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1075 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all International Medical Systems devices

FDA 510(k) Submission Details - K990515

510(k) Number K990515 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 18, 1999
Decision Date May 13, 1999
Days to Decision 84 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 131d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KNW Device Classification - Class 2, Special Controls

Product Code KNW Instrument, Biopsy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1075
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KNW Instrument, Biopsy

All 293
Devices cleared under the same product code (KNW) and FDA review panel - the closest regulatory comparables to K990515.
TRU-CORE I REUSABLE BIOPSY INSTRUMENT
K990839 · Medical Device Technologies, Inc. · May 1999
GALLINI ATRA-CUT NEEDLE
K990645 · Gallini U.S., LLC · May 1999
GALLINI BYCUT NEEDLE
K990716 · Gallini U.S., LLC · May 1999
DAUM NEUROGATE TROCAR
K990782 · Daum GmbH · Apr 1999
DAUM NEUROCUT NEUROBIOPSYNEEDLE
K990278 · Daum Corp. · Mar 1999
MEDSOL GOLDENBERG BONE MARROW BIOPSY NEEDLE
K983187 · Medsol Corp. · Dec 1998